CVS Caremark Settles FTC Litigation with New Pricing Transparency Rules
CVS Caremark has reached a global settlement with the Federal Trade Commission, ending long-standing litigation over its pharmacy benefit management practices. The agreement forces the company to overhaul its pricing structures, mandate point-of-sale rebates, and implement strict disclosure requirements for drug costs and broker compensation across its network.






.webp&w=3840&q=75)



















